Multiple Sclerosis and Related Disorders
Publisher: Elsevier · ISSN 2211-0348 · 60 articles
- Family planning in multiple sclerosis: An Australian perspective
- The implications of biotin supplementation on multiple sclerosis, hair loss conditions, and thyroid disorders
- Latin American consensus recommendations on the role of magnetic resonance imaging in neuromyelitis optica spectrum disorder in clinical practice
- Effects of blood flow restriction therapy on lower-limb strength in multiple sclerosis: A systematic review and meta-analysis
- Mandatory national clinical audits as a tool to drive improvements in multiple sclerosis outcomes
- Unilateral MR-guided laser interstitial thermal therapy thalamotomy for refractory multiple sclerosis tremor: 12-month outcomes in four patients
- Longitudinal humoral and cellular immune responses to COVID-19 vaccination in persons with multiple sclerosis across disease-modifying therapy classes
- Early myelin-associated histological and cellular findings following ketogenic diet or ketone ester treatment in a cuprizone/rapamycin mouse model
- Normal pressure hydrocephalus in people with multiple sclerosis
- Examining intersections of biographies & biologies: Diversity & outcomes of people with multiple sclerosis in Canada (iBio2Div-MS) protocol
- Walking and strength outcomes of targeted hip resistance training may be predicted by both MRI and clinical measures in multiple sclerosis
- Reduced perivascular diffusion in multiple sclerosis is associated with aging, disease duration, and mobility impairment
- Characterization of distinct cognitive domain patterns in AQP4-IgG-positive NMOSD: A MoCA-based factor analysis and risk profiling
- Sudomotor dysfunction in multiple sclerosis: A systematic review and meta-analysis
- Short term effect of repetitive transcranial magnetic stimulation of the medial sensorimotor cortex for neurogenic pelvic floor dysfunction in multiple sclerosis: a randomized, double blind, sham controlled trial
- Autoimmune comorbidity profiles in MOGAD and AQP4-NMOSD: a real-world evidence study of top 10 autoimmune disorders across the pre- and post-COVID-19 eras
- Real-world treatment in pediatric-onset multiple sclerosis: Data from the Swiss pediatric inflammatory brain disease cohort study
- Impact of newly diagnosed multiple sclerosis on marital status and partner relationship
- Diet quality, gut microbiome diversity, and clinical disability in multiple sclerosis: A cross-sectional case-control study
- Phase-associated differences in perivascular and glymphatic-related MRI markers in AQP4-IgG-seropositive neuromyelitis Optica spectrum disorder: A cross-sectional study
- Depressive symptoms and CSF markers of B-cell activation in multiple sclerosis
- Multiple sclerosis burden: global versus MENA region (1990 to 2023), with mortality projections to 2050: A pairwise GBD analysis
- The role of comorbidities in comprehensive healthcare utilization among people with multiple sclerosis
- Fumarate-induced lymphopenia in multiple sclerosis: A retrospective analysis
- False-positive cases classified by the 2022 optic neuritis criteria: clinical and radiological features
- Higher fitness levels associate with higher brain volume and lower lesion volume in youth with Multiple Sclerosis
- Multiple sclerosis and concomitant rheumatologic diseases: prevalence and management
- Cognitive resilience and improvements in health-related quality of life over 4 years in people with relapsing multiple sclerosis treated with cladribine tablets: Results from the CLARIFY-MS Extension study
- Gut microbiome and physical activity in paediatric-onset multiple sclerosis
- Low-fat diet reduces fatigue and alters serum metabolomic pathways in people with multiple sclerosis: a sub-study of a randomized controlled trial